Development and validation of a transcriptomic and genomic signature of acquired radioresistance in muscle-invasive bladder cancer

Closing date: 23/11/2026

Clinical Research Training Fellowship: Development and validation of a transcriptomic and genomic signature of acquired radioresistance in muscle-invasive bladder cancer 

Lead Supervisors: Professor Ananya Choudhury
Co-Supervisors: 
Dr Luisa Vanesa Biolatti, Dr Amen Shamin, Professor Peter Hoskin, Professor Ludwig Dubois

Applications Deadline: 12:00pm Monday 23rd November 2026
Interviews: Friday 5th February 2027 (in Manchester) 
Start date: September 2027

Project Keywords: bladder, radiosensitivity, biomarker
Research Opportunity: Clinical Research Training Fellowship leading to the award of PhD

Project Outline

Bladder cancer affects around 614,000 people worldwide each year. Muscle-invasive bladder cancer (MIBC) is the most aggressive form of the disease and can be difficult to treat. Patients are usually offered either surgery to remove the bladder or radiotherapy. Unlike surgery, radiotherapy can preserve the bladder and help maintain quality of life. However, approximately one-third of patients experience their cancer returning after radiotherapy. Currently, we do not have a reliable way of identifying which patients are most likely to benefit from radiotherapy.

This PhD project aims to understand why some bladder cancers are resistant to radiotherapy. The successful candidate will use unique laboratory models of radiotherapy-resistant bladder cancer developed within our group, to investigate the biological changes that allow some cancers to survive treatment. They will use advanced techniques to study changes in genes and gene activity within cancer cells. A particular focus will be on tumour hypoxia (areas of low oxygen levels within tumours), which can make radiotherapy less effective.

The project will combine laboratory research with the analysis of data and tumour samples from major clinical trials, to identify biological markers that could help predict whether a patient’s cancer is likely to respond to radiotherapy. The fellow will gain experience in cancer biology, molecular profiling, bioinformatics, biomarker discovery, and translational research, working within a multidisciplinary team of laboratory scientists, clinicians and computational biologists. This provides excellent training for a future career in clinical academia.

The long-term goal of this research is to develop biomarkers that will help doctors select the most effective treatment for each patient. By optimising the use of bladder-preserving radiotherapy, this work has the potential to reduce cancer recurrence and spare patients from unnecessary treatment, potentially improving both survival and quality of life for people with bladder cancer.

Applications for this project are now open. Please complete your application on The University of Manchester website.

About Professor Ananya Choudhury (project Lead Supervisor)

Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She joined The Christie in 2008 specialising in urology and sarcoma and has a strong interest in translational research. In 2013, she decided to focus on radiotherapy-related research in prostate and bladder cancers. She is clinical lead for advanced radiotherapy, including the MRLinac project, and is co-Group Leader of The Translational Radiobiology Group within the Division of Cancer Sciences. Professor Choudhury currently undertakes research which aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side effects and predictive biomarkers to determine which patients benefit from different treatments.

Find out more

Ananya Choudhury headshot

Key information

Before submitting an application, please ensure you have read the information below about the funding arrangements and eligibility for our Clinical Research Training Fellowships.

We also encourage you to get in contact with the lead supervisor to discuss the project and any particulars.

Further information is available on the Clinical Research Training Fellowships webpage.

Useful Links

Submit your application

Interested in applying for this opportunity? Submit your application on The University of Manchester application portal.

Clinical Research Training Fellowships

Discover our various opportunities for clinicians looking to undertake a period of PhD training in a cancer-relevant field.

Get in Touch

Contact Dr Yasmin Noori Jenaghard, Postgraduate Programme Manager.

Researcher Stories

Read first-hand experiences of from cancer scientists from across Manchester.

Why Manchester?

Find out why postgraduate students choose to study in Manchester.

A Day in the Life of a Clinical PhD Student

Watch our short video to see what it's like to be a Clinical Research Training Fellow in Manchester.